For instance, several studies have investigated UCH-L1 levels both centrally, in particular in the cerebrospinal fluid (CSF), and systemically, in the plasma, considering AD cohorts with varying degrees of cognitive decline and comparing their findings with other clinically well-recognized biomarkers [101,102,103,104,105,106,107,108,109]. Here, UCHL1 is linked to Alzheimer disease.